Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men

Clinical Endocrinology

Volumn 66, Issue 3, 2007, Pages 394-398

  Pour, Hamid Reza Nakhai ^a   Grobbee, Diederick E ^a   Muller, Majon ^a   Van Der Schouw, Yvonne T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; PRASTERONE SULFATE; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; SENESCENCE; SEX HORMONE DETERMINATION; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 33846931794     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02745.x     Document Type: Article

References (35)

1. Lamberts, S.W.J., van den Beld, A.W. & van der Lely, A.-J. (1997) The endocrinology of aging. Science, 278, 419-424.
2. Thom, T. (1989) International mortality from heart disease: rates and trends. International Journal of Epidemiology, 18, S20-S28.
3. Vermeulen, A. & Kaufman, J.M. (1995) Ageing of the hypothalamopituitary-testicular axis in men. Hormone Research, 43, 25-28.
4. English, K.M., Mandour, O., Steeds, R.P., Diver, M.J., Jones, T.H. & Channer, K.S. (2000) Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. European Heart Journal, 21, 890-894.
5. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. & Hennekens, C.H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336, 973-979.
6. Liuzzo, G., Biasucci, L.M., Gallimore, J.R., Grillo, R.L., Rebuzzi, A.G., Pepys, M.B. & Maseri, A. (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New England Journal of Medicine, 331, 417-424.
7. Abbott, R.D., Curb, J.D., Rodriguez, B.L., Masaki, K.H., Yano, K., Schatz, I.J., Ross, G.W. & Petrovitch, H. (2002) Age-related changes in risk factor effects on the incidence of coronary heart disease. Annals of Epidemiology, 12, 173-181.
8. Cushman, M., Meilahn, E.N., Psaty, B.M., Kuller, L.H., Dobs, A.S. & Tracy, R.P. (1999) Hormone replacement therapy, inflammation and hemostasis in elderly women. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 893-899.
9. Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M.L., Kessler, C., Judd, H.L., Sakkinen, P.A. & Tracy, R.P. (1999) Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation, 100, 717-722.
10. Hu, P., Greendale, G.A., Palla, S.L., Reboussin, B.A., Herrington, D.M., Barrett-Connor, E. & Reuben, D.B. (2005) The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial. Atherosclerosis, 185, 347-352.
11. Barnes, J.F., Farish, E., Rankin, M. & Hart, D.M. (2005) Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine. Menopause, 12, 92-98.
12. Ridker, P.M., Hennekens, C.H., Rifai, N., Buring, J.E. & Manson, J.E. (1999) Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation, 100, 713-716.
13. Khosla, S., Atkinson, E.J., Dunstan, C.R. & O'Fallon, W.M. (2002) Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. Journal of Clinical Endocrinology and Metabolism, 87, 1550-1554.
14. Muller, M., Grobbee, D.E., den Tonkelaar, I., Lamberts, S.W.J. & van der Schouw, Y.T. (2005) Endogenous sex hormones and metabolic syndrome in aging men. Journal of Clinical Endocrinology and Metabolism, 90, 2618-2623.
15. Vermeulen, A., Verdonck, L. & Kaufman, J.M. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism, 84, 3666-3672.
16. Sodergard, R., Backstrom, T., Shanbhag, V. & Carstensen, H. (1982) Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. Journal of Steroid Biochemistry, 16, 801-810.
17. Stolk, R.P., Wink, O., Zelissen, P.M., Meijer, R., van Gils, A.P. & Grobbee, D.E. (2001) Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. International Journal of Obesity and Related Metabolic Disorders, 25, 1346-1351.
18. Rinaldi, S., Dechaud, H., Biessy, C., Morin-Raverot, V., Toniolo, P., Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Shore, R.E., Secreto, G., Ciampi, A., Riboli, E. & Kaaks, R. (2001) Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiology, Biomarkers and Prevention, 10, 757-765.
19. Bremner, W.J., Vitiello, M.V. & Prinz, P.N. (1983) Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. Journal of Clinical Endocrinology and Metabolism, 56, 1278-1281.
20. Tanko, L.B., Bruun, J.M., Alexandersen, P., Bagger, Y.Z., Richelsen, B., Christiansen, C. & Larsen, P.J. (2004) Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation, 110, 2246-2252.
21. Park, H.S., Park, J.Y. & Yu, R. (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-[alpha] and IL-6. Diabetes Research and Clinical Practice, 69, 29-35.
22. Piche, M.-E., Lemieux, S., Weisnagel, S.J., Corneau, L., Nadeau, A. & Bergeron, J. (2005) Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. American Journal of Cardiology, 96, 92-97.
23. Maggio, M., Basaria, S., Ble, A., Lauretani, F., Bandinelli, S., Ceda, G.P., Valenti, G., Ling, S.M. & Ferrucci, L. (2006) Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. Journal of Clinical Endocrinology and Metabolism, 91, 345-347.
24. Van Pottelbergh, I., Braeckman, L., De Bacquer, D., De Backer, G. & Kaufman, J.M. (2003) Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis, 166, 95-102.
25. Laaksonen, D.E., Niskanen, L., Punnonen, K., Nyyssonen, K., Tuomainen, T.P., Salonen, R., Rauramaa, R. & Salonen, J.T. (2003) Sex hormones, inflammation and the metabolic syndrome: a population-based study. European Journal of Endocrinology, 149, 601-608.
26. Kovacs, A., Henriksson, P., Hamsten, A., Wallen, H., Bjorkegren, J. & Tornvall, P. (2005) Hormonal regulation of circulating C-reactive protein in men. Clinical Chemistry, 51, 911-913.
27. MacDonald, P.C., Madden, J.D., Brenner, P.F., Wilson, J.D. & Siiteri, P.K. (1979) Origin of estrogen in normal men and in women with testicular feminization. Journal of Clinical Endocrinology and Metabolism, 49, 905-916.
28. Vermeulen, A.K.J., Goemaere, S. & van Pottelberg, I. (2002) Estradiol in elderly men. Aging Male, 5, 98-102.
29. Cohen, P.G. (2001) Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Medical Hypotheses, 56, 702-708.
30. Vongpatanasin, W., Tuncel, M., Wang, Z., Arbique, D., Mehrad, B. & Jialal, I. (2003) Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. Journal of the American College of Cardiology, 41, 1358-1363.
31. Prestwood, K.M., Unson, C., Kulldorff, M. & Cushman, M. (2004) The effect of different doses of micronized 17{beta}-estradiol on C-reactive protein, interleukin-6, and lipids in older women. Journals of Gerontology. Series A, Biology Sciences and Medical Sciences, 59, M827-M832.
32. Kousteni, S., Han, L., Chen, J.-R., Almeida, M., Plotkin, L., Bellido, T. & Manolagas, S.C. (2003) Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. Journal of Clinical Investigation, 111, 1651-1664.
33. Trayhurn, P. & Wood, I.S.A. (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition, 92, 347-355.
34. Bruun, J.M., Lihn, A.S., Verdich, C., Pedersen, S.B., Toubro, S., Astrup, A. & Richelsen, B. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. American Journal of Physiology. Endocrinology and Metabolism, 285, E527-E533.
35. Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G.D.O., Pepys, M.B. & Gudnason, V. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350, 1387-1397.